China Pharma Holdings, Inc.
CPHI
$0.44-0.07 (13.00%)Nov 20
After-hours: $0.44 (+0.00%)
China Pharma Holdings, Inc. (CPHI)
$0.44-0.07-13.00%Nov 20
Loading chart…
YTD-64%
M.cap.19 mn
Std.Dev, 1y-0.83
Vol, bn0.0 (med)
RSI26 (oversold)
P/E—
MFI38
P/S4.55
ADX51 (trend)
P/B0.48
Beta1.07
Div—
Debt/EBITDA—
Payout—
Price target
Next earnings—
Earnings surprise
Short interest0.1% (-0.1%), 15 Jun 2026
Fund owners #8 (-1)
Insider ownership$0 mm
Insider selling—
Insider buying—
General
M.Cap$19M
Dividends—
Next report—
Forecast
Valuation
Target
P/E—
P/S4.55
P/B0.48
Fundamentals
5-y avg sales growth-17.5%
Debt / EBITDA0.00
ROE—
Altman Z-score-2.15 (distress)
Technicals
RSI26
MFI38
Price / MA50-33.5% (v.low) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

China Pharma Holdings, Inc. is a Chinese pharmaceutical company that develops, manufactures, and markets generic and branded pharmaceutical and biological products to hospitals and private retailers in the People's Republic of China. The company offers various medical products to treat a wide range of conditions, from memory decline to digestive diseases, as well as sanitizers and masks. Its products are sold through a network of 16 sales offices and approximately 1,000 sales representatives across China.

Headcount: 215
Address:No. 17, Jinpan Road, Haikou, China, 570216
About

China Pharma Holdings, Inc. is a Chinese pharmaceutical company that develops, manufactures, and markets generic and branded pharmaceutical and biological products to hospitals and private retailers in the People's Republic of China. The company offers various medical products to treat a wide range of conditions, from memory decline to digestive diseases, as well as sanitizers and masks. Its products are sold through a network of 16 sales offices and approximately 1,000 sales representatives across China.

https://www.chinapharmaholdings.com
Beta 1.07